Fig. 1From: Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trialPatient flow chart (Consolidated Standards of Reporting Trials/CONSORT diagram)Back to article page